Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis.

Hermans, Cédric;Lambert, Catherine
(2020) Journal of thrombosis and haemostasis : JTH — Vol. 18, n° 7, p. 1794-1795 (2020)

Files

2020_Hermans_J_Thromb_Haemost_14845.pdf
  • Open Access
  • Adobe PDF
  • 258.28 KB
Download

Details

Authors
Abstract
Major therapeutic developments have been achieved in the field of thrombotic and hemorrhagic diseases over the last decade. These include the development and validation of four direct oral anticoagulants (DOACs) indicated for numerous thrombotic disorders, both arterial and venous. 1 Developments also involve new hemostatic agents for hemophilia patients, in particular factor VIII (FVIII) and factor IX (FIX) concentrates with extended half‐life (EHL) 2 , 3 and a bispecific antibody mimicking the action of FVIII (emicizumab) [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hermans, C., & Lambert, C. (2020). Impact of the COVID-19 pandemic on therapeutic choices in thrombosis-hemostasis. Journal of thrombosis and haemostasis : JTH, 18(7), 1794-1795. https://doi.org/10.1111/jth.14845 (Original work published 2020)